MedTrace Logo

Routine Angiography Follow-Up After Percutaneous Coronary Intervention in High-Risk Patients

NCT05923489 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 2618

Last updated 2023-12-07

No results posted yet for this study

Summary

Comparison of clinical outcomes between routine angiography follow-up and routine clinical follow-up after percutaneous coronary intervention in high-risk patients.

Conditions

Interventions

DIAGNOSTIC_TEST

Routine Angiography Follow-up

Patients in the RAF group will have routine angiography follow-up at 12 months after revascularization.

DIAGNOSTIC_TEST

Routine Clinical Follow-up

Patients in the RCF group will have routine clinical follow-up at 12 months after revascularization, and the physician will decide whether further invasive testing is needed.

Sponsors & Collaborators

  • Jinhua Central Hospital

    collaborator OTHER

  • Changxing People's Hospital

    collaborator OTHER

  • The Affiliated Hospital of Hangzhou Normal University

    collaborator OTHER

  • Second Affiliated Hospital of Shantou University Medical College

    collaborator OTHER

  • Dongyang People's Hospital

    collaborator OTHER

  • First Affiliated Hospital of Wenzhou Medical University

    collaborator OTHER

  • Huizhou Municipal Central Hospital

    collaborator OTHER

  • First Affiliated Hospital of Ningbo University

    collaborator NETWORK

  • Second Affiliated Hospital, School of Medicine, Zhejiang University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-10-26
Primary Completion
2026-10-15
Completion
2029-10-15

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05923489 on ClinicalTrials.gov